Gisele Dion
Director/Board Member at CYTEK BIOSCIENCES, INC.
Net worth: 28 150 $ as of 2024-04-29
Profile
Gisele Dion is currently the Director at Inhibikase Therapeutics, Inc. and an Independent Director at Cytek Biosciences, Inc. She previously worked as the Senior Director-Technical Accounting & Controller at Biogen, Inc. from 2007 to 2016, and as the Chief Accounting Officer at Shire Plc from 2017 to 2019.
She also served as the Chief Accounting Officer, Senior VP & Controller at Takeda Pharmaceutical Co., Ltd.
from 2019 to 2021, and at Shire Pharmaceuticals LLC from 2016 to 2019.
Ms. Dion received her undergraduate degree from Fairfield University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYTEK BIOSCIENCES, INC.
0.00% | 2024-03-30 | 5,000 ( 0.00% ) | 28 150 $ | 2024-04-29 |
| 2024-04-14 | 0 ( -.--% ) | - $ | 2024-04-29 |
Gisele Dion active positions
| Companies | Position | Start |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Director/Board Member | 2021-02-28 |
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 2022-08-31 |
Former positions of Gisele Dion
| Companies | Position | End |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Comptroller/Controller/Auditor | 2021-02-28 |
| SHIRE | Comptroller/Controller/Auditor | 2018-12-31 |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Comptroller/Controller/Auditor | 2018-12-31 |
| BIOGEN INC. | Comptroller/Controller/Auditor | 2015-12-31 |
Training of Gisele Dion
| Fairfield University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| CYTEK BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Gisele Dion
